166 related articles for article (PubMed ID: 119355)
1. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
Danhof M; Krom DP; Breimer DD
Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355
[TBL] [Abstract][Full Text] [Related]
2. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo.
Teunissen MW; Joeres RP; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Apr; 13(4):223-31. PubMed ID: 6624137
[TBL] [Abstract][Full Text] [Related]
3. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver.
Kahn GC; Boobis AR; Murray S; Davies DS
Xenobiotica; 1982 Aug; 12(8):509-16. PubMed ID: 7147996
[TBL] [Abstract][Full Text] [Related]
5. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
Teunissen MW; Van Graft M; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of antipyrine and m-xylene in rats after prolonged pretreatment with xylene alone or xylene with ethanol, phenobarbital or 3-methylcholanthrene.
Elovaara E; Engström K; Häyri L; Hase T; Aitio A
Xenobiotica; 1989 Sep; 19(9):945-60. PubMed ID: 2815836
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene.
Groen K; Breimer DD; van Bezooijen CF
Drug Metab Dispos; 1992; 20(4):502-6. PubMed ID: 1356725
[TBL] [Abstract][Full Text] [Related]
8. Influence of cigarette smoke on antipyrine metabolite formation in rats.
Nakagawa A; Chiba K; Ishizaki T; Nakamura K
Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):473-91. PubMed ID: 6635330
[TBL] [Abstract][Full Text] [Related]
9. Studies on in vitro antipyrine metabolism by 13C,15N double labeled method.
Nakagawa A; Nakamura K; Maeda K; Kamataki T; Kato R
Life Sci; 1987 Jul; 41(2):133-43. PubMed ID: 3298908
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of metronidazole and antipyrine in isolated rat hepatocytes. Influence of sex and enzyme induction and inhibition.
Loft S; Poulsen HE
Biochem Pharmacol; 1989 Apr; 38(7):1125-36. PubMed ID: 2706012
[TBL] [Abstract][Full Text] [Related]
11. Human metabolism of antipyrine labelled with 14C in the pyrazolone ring or in the N-methyl group.
Uchino H; Inaba T; Kalow W
Xenobiotica; 1983 Mar; 13(3):155-62. PubMed ID: 6613161
[TBL] [Abstract][Full Text] [Related]
12. The effect of age on antipyrine metabolism by liver microsomes isolated from phenobarbital-treated rats.
Henderson DJ; van Bezooijen CF
Mech Ageing Dev; 1989 Sep; 49(3):287-94. PubMed ID: 2811495
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic method for the determination of the three main oxidative and 3-carboxylic antipyrine metabolites in human urine.
Palette C; Cordonnier P; Naline E; Advenier C; Pays M
J Chromatogr; 1991 Jan; 563(1):103-13. PubMed ID: 2061375
[TBL] [Abstract][Full Text] [Related]
14. The effect of malaria infection on antipyrine metabolite formation in the rat.
Mansor SM; Ward SA; Edwards G
Biochem Pharmacol; 1991 Apr; 41(8):1264-6. PubMed ID: 2009102
[TBL] [Abstract][Full Text] [Related]
15. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.
Tanaka E; Kobayashi S; Aramphongphan A; Kurata N; Oguchi K; Kuroiwa Y; Yasuhara H
J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137
[TBL] [Abstract][Full Text] [Related]
16. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
Leclercq V; Desager JP; Horsmans Y; Van Nieuwenhuyze Y; Harvengt C
Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of norantipyrine sulphate and norantipyrine glucuronide as major metabolites of antipyrine in man and rat.
Böttcher J; Bässmann H; Schüppel R
J Pharm Pharmacol; 1984 Jun; 36(6):391-8. PubMed ID: 6146671
[TBL] [Abstract][Full Text] [Related]
18. Effect of spironolactone on antipyrine metabolism in calves.
Janus K; Suszycka J
Res Vet Sci; 1996 Jul; 61(1):87-8. PubMed ID: 8819201
[TBL] [Abstract][Full Text] [Related]
19. Antipyrine clearance and metabolite formation in children with congenital adrenal hyperplasia.
Teunissen MW; Bruining GJ; De Jongh BM; Tenkate-Westerhof EW; Breimer DD
Br J Clin Pharmacol; 1985 Dec; 20(6):703-6. PubMed ID: 4092001
[TBL] [Abstract][Full Text] [Related]
20. Effects of flumethrin on hepatic drug-metabolizing enzymes and antipyrine disposition in rats.
Anadón A; Martinez-Larrañaga MR; Diaz MJ; Bringas P; Fernandez MC; Martinez MA; Fernandez-Cruz ML
Toxicol Appl Pharmacol; 1995 May; 132(1):14-8. PubMed ID: 7747277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
